Literature DB >> 1295377

Comparative study of effects of cyclosporins A and G on collagen arthritis in mice.

K Takagishi1, M Yamamoto, H Miyahara, T Hotokebuchi, N Kaibara.   

Abstract

The effects of the immunosuppressive agents cyclosporin G (CsG) and cyclosporin A (CsA) on collagen arthritis were compared in mice. When administered subcutaneously daily on days 0-13 after immunization with type II collagen, CsG and CsA were both capable of suppressing the development of collagen arthritis in mice as well as the immunological response to native type II collagen in a dose-dependent manner. Histopathologically, no marked inflammatory lesions were observed in diarthroidal joints from mice treated with 100 mg/kg per day of CsA or 800 mg/kg per day of CsG. However, an analysis of dose response showed CsG to be 8 times less potent than CsA in inhibiting the development of arthritis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1295377     DOI: 10.1007/bf02028121

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  25 in total

1.  Longterm cyclosporine therapy in rheumatoid arthritis.

Authors:  A W van Rijthoven; B A Dijkmans; H S Goei Thè; M Boers; A Cats
Journal:  J Rheumatol       Date:  1991-01       Impact factor: 4.666

2.  Effects of FK-506 on collagen arthritis in mice.

Authors:  K Takagishi; M Yamamoto; A Nishimura; G Yamasaki; N Kanazawa; T Hotokebuchi; N Kaibara
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

3.  Comparison of the pharmacological profiles of cyclosporine, (Nva2)-cyclosporine and (Val2)dihydro-cyclosporine.

Authors:  P C Hiestand; H C Gunn; J M Gale; B Ryffel; J F Borel
Journal:  Immunology       Date:  1985-06       Impact factor: 7.397

4.  Analysis of the immunosuppressive and nephrotoxic effects of cyclosporin G.

Authors:  E G Hoyt; R C Hagberg; M E Billingham; J C Baldwin; S W Jamieson
Journal:  J Heart Transplant       Date:  1988 Mar-Apr

5.  Serum transfer of collagen arthritis in congenitally athymic nude rats.

Authors:  K Takagishi; N Kaibara; T Hotokebuchi; C Arita; M Morinaga; K Arai
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

6.  Cyclosporine G and D in experimental autoimmune uveoretinitis in the rat.

Authors:  H Kawashima; M Mochizuki; A Okumura; Y Fujino; T Tange; D Horiuchi; E Higashihara; H Kaku; G Inaba
Journal:  Jpn J Ophthalmol       Date:  1989       Impact factor: 2.447

7.  A comparison of the effectiveness of cyclosporine A, D, and G in the treatment of experimental autoimmune uveitis in rats.

Authors:  R B Nussenblatt; R R Caspi; W J Dinning; A G Palestine; P Hiestand; J Borel
Journal:  J Immunopharmacol       Date:  1986

8.  Effects of cyclosporin on collagen induced arthritis in mice.

Authors:  K Takagishi; N Kaibara; T Hotokebuchi; C Arita; M Morinaga; K Arai
Journal:  Ann Rheum Dis       Date:  1986-04       Impact factor: 19.103

9.  Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis.

Authors:  J M Stuart; M A Cremer; A S Townes; A H Kang
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

10.  Autoimmunity to type II collagen an experimental model of arthritis.

Authors:  D E Trentham; A S Townes; A H Kang
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

View more
  2 in total

1.  Effects of cyclosporin on serum hyaluronan levels in collagen arthritis.

Authors:  K Takagishi; M Itoman; Y Goso; S Kuwao; H Miyahara; N Kaibara
Journal:  Inflamm Res       Date:  1995-02       Impact factor: 4.575

Review 2.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.